Aditxt, Inc. — Investor Relations & Filings
Filings indexed
531
across all filing types
Latest filing
2026-04-14
Regulatory Filings
Country
US
United States of America
Listing
US
ADTX
Aditxt, Inc. is an innovation company focused on acquiring, developing, and deploying promising health technologies. Its business model involves acquiring disruptive and scalable companies, leveraging its business acceleration platform to drive growth, and monetizing assets through various strategies including mergers, sales, and licenses. The company's portfolio of programs targets significant health challenges. Current programs include Adimune, focused on autoimmunity; Pearsanta, for early cancer detection; and Adivue, for neurological diagnostics. Aditxt also has planned programs and proposed acquisitions in areas such as reproductive health.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Aditxt, Inc. (0001726711) (Filer) | 2026-04-14 | English | |
| S-3 - Aditxt, Inc. (0001726711) (Filer) | 2026-04-11 | English | |
| 8-K/A - Aditxt, Inc. (0001726711) (Filer) | 2026-04-07 | English | |
| DEF 14A - Aditxt, Inc. (0001726711) (Filer) | 2026-04-03 | English | |
| 8-K - Aditxt, Inc. (0001726711) (Filer) | 2026-04-02 | English | |
| 8-K - Aditxt, Inc. (0001726711) (Filer) | 2026-03-30 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 34484140 | 8-K - Aditxt, Inc. (0001726711) (Filer) | 2026-04-14 | English | ||
| 34402623 | S-3 - Aditxt, Inc. (0001726711) (Filer) | 2026-04-11 | English | ||
| 33743863 | 8-K/A - Aditxt, Inc. (0001726711) (Filer) | 2026-04-07 | English | ||
| 33302978 | DEF 14A - Aditxt, Inc. (0001726711) (Filer) | 2026-04-03 | English | ||
| 33158825 | 8-K - Aditxt, Inc. (0001726711) (Filer) | 2026-04-02 | English | ||
| 33087919 | 8-K - Aditxt, Inc. (0001726711) (Filer) | 2026-03-30 | English | ||
| 33066090 | 424B5 - Aditxt, Inc. (0001726711) (Filer) | 2026-03-27 | English | ||
| 31498298 | 8-K Filing | 2026-02-13 | English | ||
| 31498392 | 8-K Filing | 2026-01-30 | English | ||
| 31498344 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 31498281 | 8-K Filing | 2026-01-28 | English | ||
|
2025
4 filings
| |||||
| 13087095 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13087096 | DEFINITIVE PROXY STATEMENT | 2025-12-16 | English | ||
| 13087097 | PROSPECTUS SUPPLEMENT | 2025-12-12 | English | ||
| 13087099 | REVISED PRELIMINARY PROXY STATEMENT | 2025-12-05 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ALTERITY THERAPEUTICS LIMITED
Clinical-stage developer of disease-modifying therapies for…
|
ATH | AU | Professional, scientific and te… |
|
AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheim…
|
ALZCUR | SE | Professional, scientific and te… |
|
AMPLIA THERAPEUTICS LIMITED
Clinical-stage developer of FAK inhibitors for solid tumors…
|
ATX | AU | Professional, scientific and te… |
|
ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapeutics f…
|
ANAB | US | Professional, scientific and te… |
|
ANATARA LIFESCIENCES LTD
Develops non-antibiotic gastrointestinal health solutions f…
|
ANR | AU | Professional, scientific and te… |
|
AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and he…
|
251280 | KR | Professional, scientific and te… |
|
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
Pharmaceutical CRO specializing in clinical trials, BE stud…
|
301520 | CN | Professional, scientific and te… |
|
Anixa Biosciences Inc
A clinical-stage biotech developing therapies and vaccines …
|
ANIX | US | Professional, scientific and te… |
|
Annovis Bio, Inc.
A clinical-stage drug platform company developing therapies…
|
ANVS | US | Professional, scientific and te… |
|
AnorMED Inc.
Developed small molecule therapeutics for serious diseases,…
|
— | CA | Professional, scientific and te… |
Aditxt, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35447/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35447 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35447 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35447 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35447}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aditxt, Inc. (id: 35447)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.